vst ::: reviews :: visions on the future of veterinary virology


		Visions on the Future of Veterinary Virology Feline Infectious Peritonitis

		Potassium Homeostasis During Exercise Mini-review: Species-specific Primary Cell Cultures



		· Introduction · Emerging viruses and virus-like agents · Co-evolution of viruses and host defence mechanisms · Development of vaccines · Gene therapy · Acknowledgments · References
		email this article quick print download pdf-file

you are here > home > reviews > visions on the future... > references

References
1.Alexander L., Weiskopf E., Greenough T. C., Gaddis N. C., Auerbach M. R., Malim M. H., O'Brien S. J., Walker B. D., Sullivan J. L., Desrosiers R. C. (2000). Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection. J. Virol. 74(9): 4361-4376.

2. Allen G.M., Meehan B., Todd D., Kennedy S. McNeilly F., Ellis J., Clark E.G., Harding J., Espuna E., Botner A., Charreyre C. (1998). Novel porcine circoviruses from pigs with wasting disease syndromes. Vet. Rec. 142: 467-468.

3. Anchlan D., Ludwig S., Nymadawa P. Mendsaikhan J., and Scholtissek C. (1996). Previous H1N1 influenza A viruses circulating in the Mongolian population. Arch. Virol. 141: 1553-1569.

4. Chen Y., Winchester R., Korber B., Gagliano J., Bryson Y., Hutto C., Martin N., McSherry G., Petru A., Wara D., Ammann A. (1997). Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: association of several HLA-DR13 alleles with long-term survivorship and the potential association of HLA-A*2301 with rapid progression to AIDS. Long-Term Survivor Study. Hum. Immunol. 55: 154-62.

5.Chua K.B., Goh K.J., Wong K.T., Kamarulzaman A., Tan P.S., Ksiazek T.G., Zaki S.R., Paul G., Lam S.K., Tan C.T. (1999). Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet 354: 1257-1259.

6. Costantini L.C., Bakowska J.C., Breakefield X.O., Isacson O. (2000). Gene therapy in the CNS. Gene Therapy 7: 93-103.

7. Costantini L.C., Jacoby D.R., Wang S., Fraefel C., Breakefield X.O., Isacson O. (1999). Gene transfer to the nigrostriatal system by hybrid herpes simplex virus/adeno-associated virus amplicon vectors. Hum. Gene Ther. 10: 2481-2494.

8. Daheshia M, Kuklin N., Kanangat S., Manickan E., Rouse BT. (1997). Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. Journal of Immunology 159:1945-52.

9. Fulker R., Wasmoen T., Atchison R., Chu H.J., and Acree W. (1995). Efficacy of an inactivated vaccine against clinical disease caused by canine coronavirus. Adv. Exp. Med. Biol. 380: 229-234.

10. Gleeson L.J. (1997). Australian bat lyssavirus - a newly emerged zoonosis? Aust. Vet. J. 75: 188.

11. Grob P, Schijns V.E., van den Broek M.F., Cox S.P., Ackermann M., Suter M. (1999). Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection. J. Virol. 73: 4748-4754.

12. Hess W.R. (1985) Introduction. pp 1-4. In "African Swine Fever" (Y. Becker, ed.) Martinus Nijhoff Publishing Boston/Dordrecht/Lancaster.

13. Hodgson C.P. (1995). The vector void in gene therapy. Biotechnology 13: 222-225.

14. Laude H. Van Reeth K., Pensaert P. (1993). Porcine respiratory coronavirus: molecular features and virus-host interactions. Vet. Res. 24: 125.150.

15. Leitner W.W., Ving H., Restifo N.P. (1999). DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 18: 765-777.

16. Luo D., Salzman W.M. (2000). Synthetic DNA delivery systems. Nature Biotechnology 18: 33-37.

17. McLean C.S., Erturk M., Jennings R. Challanain D.N., Minson A.C., Duncan I., Boursnell M.E., Inglis S.C. (1994). Protective vaccination against primary and recurrent disease caused by herpes simplex virus type 2 using a genetically disabled HSV-1. J. Infect. Dis. 170: 1100-1109.

18. Mutze G., Cooke B., Alexander P. (1998). The initial impact of rabbit hemorrhagic disease on European rabbit populations in Southern Australia. J. Wildl. Dis. 34: 221-227.

19. Rasschaert D., Duarte M., Laude H. (1990). Porcine respiratory coronavirus differs from transmissible gastroenteritis virus by a few genomic deletions. J. Gen. Virol. 71: 2599 2607.

20. Saeki Y., Ichikawa T., Saeki A., Chiocca E.A., Tobler K., Ackermann M., Breakefield X.O., Fraefel C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 9: 2787-2794.

21. Sena-Esteves M., Saeki Y., Camp S.M., Chiocca E.A., Breakefield X.O. (1999). Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons. J. Virol. 73: 10426.10439.

22. Shortridge K.F., Gao P., Guan Y., Ito T., Kawaoka Y., Markwell D., Takada A., Webster R.G. (2000). Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. Vet. Microbiol. 74: 141-147.

23. Simpson H.N. (1954). The impact of disease on American history. N. Engl. J. Med. 250: 679-682.

24. Stearn E.W. and Stearn A.E. (1945). The effect of Smallpox on the destiny of the Amerindian, 44-45, Bruce Humphries, Boston.

25. Suter M., Lew A.M., Grob P., Adema G.J., Ackermann M., Shortman K., Fraefel C. (1999). BAC-VAC, a novel generation of DNA vaccines: a bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 96: 12697-12702.

26. Tennant B.J., Gaskell R.M., Jones R.C., and Gaskell C.J. (1993). Studies on the epizootiology of canine coronavirus. Vet. Rec. 132: 7-11.

27. Thomas J. and Rouse B.T. (1997). Immunopathogenesis of herpetic ocular disease. Immunologic Research 16: 375-386.

28. Tischer I., Mields W., Wolff D., Vagt M. Griem W. (1986). Studies on epidemiology and pathogenicity of porcine circovirus. Arch. Virol. 91: 271-276.

29. Tischer I., Rasch R., Tochtermann G. (1974). Characterization of papovavirus- and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl. Bakteriol Org A 226: 153-167.

30. Whitton J.L., Oldstone B.A. (1996). "Immune response to viruses", pp 345-374. In Fields Virology Vol 1, 3rd edition, (B. Fields et al., eds.) Lippincot-Raven Publishers Philadelphia New York.

31. Zimmerman P. A., Buckler-White A., Alkhatib G., Spalding T., Kubofcik J., Combadiere C., Weissman D., Cohen O., Rubbert A., Lam G., Vaccarezza M., Kennedy P. E., Kumaraswami V., Giorgi J. V., Detels R., Hunter J., Chopek M., Berger E. A., Fauci A. S., Nutman T. B., Murphy P. M. (1997). Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3: 23-36.